Tine Rosenberg

Mrs. Tine Rosenberg


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2018 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
PDF file
TRTine Rosenberg
Tine Rosenberg
BPBahareh B Philipsen
Bahareh B Philipsen
CMCamilla S Mehlum
Camilla S Mehlum
ADAnne-Kirstine Dyrvig
Anne-Kirstine Dyrvig
SWSonja Wehberg
Sonja Wehberg
CGChristian Godballe
Christian Godballe
Recurrent respiratory papillomatosis is a benign condition caused by human papilloma virus (HPV). Surgery is the mainstay of treatment, but numerous adjuvant therapies have been applied to improve surgical outcome. Recently, HPV vaccination has been introduced, but only smaller studies of its effect have been published. The present meta-analysis is intended as a possible substitute for a proposed, but not yet realized multicenter randomized controlled trial. A systematic review and meta-analysis was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis statement. PubMed, Embase, and Cochrane were systematically searched. All retrieved studies (n=593) were reviewed and qualitatively assessed. In addition, two previously unpublished datasets were included. The systematic review included 11 studies, comprising 133 patients, of whom 63 patients from five studies were eligible for meta-analysis. A random-effects meta-analysis was conducted for the mean difference in number of surgeries per month before and after vaccination. Number of surgeries per month was significantly reduced after HPV vaccination (estimated mean 0.06) than before vaccination (estimated mean 0.35). Mean intersurgical interval increased from 7.02 months (range 0.30-45) before vaccination to 34.45 months (range 2.71-82) after HPV vaccination. The present study supports the continued use of the HPV vaccine as an adjuvant treatment for recurrent respiratory papillomatosis.

1 March 2021 in Oral Oncology
Verified
Journal Article
Open access
CAChadi Nimeh Abdel-Halim
Chadi Nimeh Abdel-Halim
TRTine Rosenberg
Tine Rosenberg
ADAnne-Kirstine Dyrvig
Anne-Kirstine Dyrvig
Poul Høilund-CarlsenPoul Høilund-Carlsen
Poul Høilund-Carlsen
JSJens Ahm Sørensen
Jens Ahm Sørensen
CGChristian Godballe
Christian Godballe
To present an up to date systematic review and meta-analysis evaluating the diagnostic accuracy of the most used imaging modalities in detection of histopathological extra nodal extension (ENE) in head and neck squamous cell carcinoma. Medline, Embase, and Cochrane databases were systematically searched on March 27th 2020. Screening, inclusion, quality assessment, and data extraction were done by two reviewers. Meta-analysis was conducted using the bivariate model approach after pooling the studies according to imaging modality. Heterogeneity was explored by meta-regression. Comparison was done by meta-regression and sub-group analyses. Out of 476 initial hits, 25 studies were included for analysis. Of these, 14 dealt with CT, nine with PET/CT, four with MRI, two with ultrasound, and none with PET/MRI. Meta-analysis based on a total sample size of 3391 showed that CT had a sensitivity of 76% [67-82%] and specificity of 77% [69-83%], MRI a sensitivity of 72% [64-79%] and specificity of 78% [57-90%], and PET/CT a sensitivity of 80% [76-84%] and specificity of 83% [74-90%] in the ability to predict ENE. No meta-analysis could be done on ultrasound. There were no significant differences between modalities in overall accuracy; however, PET/CT had significantly higher sensitivity than CT and MRI. There was no significant difference in the ability of CT, MRI, and PET/CT to diagnose histopathological ENE, except that PET/CT had a significantly higher sensitivity than CT and MRI.

10 June 2017 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
CMCamilla S. Mehlum
Camilla S. Mehlum
TRTine Rosenberg
Tine Rosenberg
ADAnne‐Kirstine Dyrvig
Anne‐Kirstine Dyrvig
AGAagot Moeller Groentved
Aagot Moeller Groentved
TKThomas Kjaergaard
Thomas Kjaergaard
CGChristian Godballe
Christian Godballe

20 May 2020 in Journal of Oral Pathology & Medicine
Verified
Journal Article
Open access
PDF file
MWMarie Westergaard‐Nielsen
Marie Westergaard‐Nielsen
TRTine Rosenberg
Tine Rosenberg
Oke GerkeOke Gerke
Oke Gerke
ADAnne‐Kirstine Dyrvig
Anne‐Kirstine Dyrvig
CGChristian Godballe
Christian Godballe
KBKristine Bjørndal
Kristine Bjørndal
Objective Elective neck dissection in patients with salivary gland carcinoma and clinical negative lymph nodes is controversial. Reported proportion of occult nodal metastases vary with histological subtype, tumour classification and preoperative diagnostic methods. This is a systematic review and meta‐analysis on the role of END in salivary gland carcinoma. Methods A search in PubMed, Embase, and Cochrane was performed. Original articles in English with data on tumour characteristics, clinical and pathological N‐classification, and neck dissection were included. Reporting Items for Systematic Reviews and Meta‐analyses were followed. Random effect modelling was performed to pool the data. Meta‐analysis of proportions was performed for occult metastases overall, for T3/T4 versus T1/T2 tumours, and for tumours with high grade versus low grade histology. Heterogeneity across studies was assessed with I‐squared statistics. Results We included 22 articles in the qualitative synthesis and meta‐analysis. The pooled proportion of occult metastases was 21%. In patients with T3/T4 tumour, the pooled proportion of occult metastases was 36%, and in patients with high grade histology it was 34%. Most studies concluded that END should be performed in patients with advanced T‐classification and high‐grade histology tumours. Nine studies assessed occult metastases per level. Conclusion The overall occult metastases proportion does not require END in all patients with salivary gland carcinoma. We recommend END in patients with high grade or unknown histology or T3/T4 tumours. END should involve level II and III, and level I should be included in tumours in the submandibular gland, sublingual gland, and minor oral salivary glands.

7 April 2020 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
MRMax Rohde
Max Rohde
TRTine Rosenberg
Tine Rosenberg
MPManan Pareek
Manan Pareek
Paul NankivellPaul Nankivell
Paul Nankivell
NSNeil Sharma
Neil Sharma
CGChristian Godballe
Christian Godballe

1 February 2018 in European Journal of Cancer
Verified
Journal Article
Open access
ARAnders B. Roennegaard
Anders B. Roennegaard
TRTine Rosenberg
Tine Rosenberg
KBKristine Bjørndal
Kristine Bjørndal
JSJens Ahm Sørensen
Jens Ahm Sørensen
JJJørgen Johansen
Jørgen Johansen
CGChristian Godballe
Christian Godballe
During the 1990s, all Nordic countries except for Denmark experienced a general increase in 5-year survival rates for cancer patients. In 2007, the Danish National Board of Health in collaboration with national multidisciplinary cancer groups and the Danish regions initiated fast-track clinical pathway solutions. The objectives of this study were 1) to present the setup of the head and neck cancer (HNC) fast-track program at Odense University Hospital (OUH) as an example of the Danish model and 2) to present patient characteristics, diagnostic outcome, cancer detection rate, and duration of the fast-track patient courses. From 1st July 2012 to 1st September 2015, all patients referred to the HNC fast-track program at OUH for diagnostics and treatment were consecutively included in the study resulting in 3165 patient courses. The overall malignancy detection rate was 40.6% and for HNC it was 29.2%. The overall median fast-track course duration was 12 days (range 0-74). Overall 2990 (94.5%) of 3165 patients completed their fast-track course within the maximally permitted course duration. Based on our findings, it was concluded that: 1) a HNC fast-track program build on pre-booked slots for diagnostics and treatment is feasible and can secure acceptable course durations for more than 90% of patient courses, 2) by using private ENT specialists as a 'filter-function', an acceptable detection rate can be achieved.